IRWD compared with MYGN: revenue, margins and what each company keeps, and the suppliers and customers both name

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

MYGNMyriad Genetics Inc

Mkt capRevenueRevenue

Compare

IRWDIronwood Pharmaceuticals Inc

MYGNMyriad Genetics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IRWD 8

ABBVAbbViesupplier

AZNAstraZeneca ABcustomer

—Ferringunlistedsupplier

—Courunlistedsupplier

4 more · IRWD chain ›

Shared 0

No shared counterparties.

Only MYGN 8

UNHUnitedHealthcarecustomer

BNRBurning Rock Biotechcustomer

—Pathomiqunlistedsupplier

—Sophia Genetics

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

4 more · MYGN chain ›

IRWDIronwood Pharmaceuticals Inc

4.02▲+6.60%· post 4.03

Mkt cap$665.9MRevenue$133MQ3 FY26Revenue$296MFY25

MYGNMyriad Genetics Inc

6.28▲+4.24%· post 6.28

ClosedNov 5 '26

Mkt cap$601.6MRevenue$191MQ2 FY26Revenue$825MFY25

Compare

ClosedNov 5 '26

IRWDIronwood Pharmaceuticals Inc

MYGNMyriad Genetics Inc

4.02▲+6.60%post 4.03

Price

6.28▲+4.24%post 6.28

$665.9M

Mkt cap

$601.6M

Q3 FY26$133M

Revenue

$191MQ2 FY26

FY25$296M

Revenue

$825MFY25

IRWD4.02▲+6.60%vsMYGN6.28▲+4.24%ClosedNov 5 '26